Skip to content (949) 720-9848
Metabolic care for women

Medically Managed Weight Loss & Metabolic Health

Move beyond generic plans with a physician-led evaluation of weight trajectory, metabolic risk, life-stage changes, current medications, and the options that may fit your health.

Prescription treatment is not automatic. Candidacy, contraindications, reproductive plans, monitoring, and alternatives are reviewed before any recommendation.

Board-Certified OB/GYNFellow of ACOGIndividualized EvaluationHoag Hospital Affiliated

What we evaluate before making a plan.

A focused consultation brings your goals into the same conversation as your medical history, current symptoms, medications, and clinically relevant findings.

01 · EVALUATE

Your health context

Review weight history, prior approaches, medical and family history, sleep, stress, symptoms, and the goals that matter to you.

02 · EVALUATE

Metabolic risk

Consider blood pressure, glucose regulation, lipids, PCOS or menopause context, and clinically relevant prior results.

03 · EVALUATE

Medication candidacy

Review current medicines, contraindications, adverse-effect risk, pregnancy intentions, and whether a prescription option is appropriate.

What care may include.

Options are selected for the individual patient. A consultation does not commit you to a test, prescription, supplement, procedure, or treatment package.

01 · PLAN

A practical foundation

Set sustainable nutrition, movement, sleep, and follow-up priorities that match your medical needs and daily life.

02 · PLAN

Prescription options

Discuss FDA-approved weight-management medication only when indicated, including expected limits, potential risks, alternatives, and monitoring.

03 · PLAN

Ongoing monitoring

Track tolerance, relevant clinical measures, changing goals, and whether the plan should continue, adjust, pause, or involve another clinician.

A clear, physician-led process.

The goal is a defensible plan with defined next steps—not a one-size-fits-all protocol.

Listen and review

Discuss your priorities, symptoms, history, medications, supplements, prior testing, and relevant life-stage considerations.

Evaluate what matters

Dr. Broad determines whether an examination, records, targeted testing, or coordination with another clinician is appropriate.

Choose and follow up

Review potential benefits, limitations, risks, alternatives, and monitoring before deciding on the next step together.

Clinical guardrails

Medication is one possible tool—not the starting assumption.

Weight-management treatment should be tied to a clinical indication and a monitoring plan. Unapproved products are not equivalent to FDA-approved medications, and pregnancy or pregnancy planning changes the conversation.

  • No medication or amount of weight loss is promised.
  • FDA-approved and compounded products are not treated as interchangeable.
  • Reproductive plans, contraindications, and adverse-effect risk are reviewed.
  • Primary-care or specialist coordination is recommended when appropriate.

Frequently asked questions.

Straight answers before you schedule.

Does the consultation guarantee a GLP-1 prescription?
No. The visit is an individualized medical evaluation, not a prescription guarantee. Dr. Broad reviews your history, goals, contraindications, reproductive plans, and the benefits and risks of appropriate options before making any recommendation.
Who may qualify for prescription weight-management medication?
Eligibility depends on the specific medication, FDA labeling, health history, current measurements, related conditions, contraindications, and clinical judgment. An appointment is needed to determine whether medication is appropriate for you.
Can we discuss PCOS or menopause-related weight changes?
Yes. PCOS, perimenopause, menopause, sleep, medications, and other health factors may be relevant to your evaluation. They do not automatically identify one cause or one treatment.
What monitoring may be needed?
Monitoring depends on your plan and may include follow-up symptoms, side effects, clinical measurements, and targeted laboratory testing when indicated. Dr. Broad explains the monitoring plan before treatment.
Is compounded GLP-1 medication the same as an FDA-approved drug?
No. FDA states that compounded drugs are not FDA approved and are not reviewed for safety, effectiveness, or quality before marketing. Dr. Broad can explain appropriate, legally available options and their limitations.
Schedule your consultation

Start with a conversation.

Share your contact information and our office will call you to discuss scheduling. Please do not send medical details through this form.

Prefer to speak with the office now? Call (949) 720-9848 Monday through Friday, 9:00 AM to 5:00 PM.

Broad Medical Group1640 Newport Blvd
Costa Mesa, CA 92627
Open in Google Maps

Request an appointment

Our team will contact you within one business day.

Important: This form is not a secure channel for medical information. Do not include diagnoses, medications, laboratory results, or other sensitive information. It is not for emergencies; call 911 for a medical emergency. By submitting, you agree to our Privacy Policy and Terms.